Skin aging.
Conditions
Interventions
Intervention group: INOVOSENSE MESOCELL PLUS mesogel injection for improvement of face skin elasticity and rejuvenation. the products are in the 2 ml prefilled sterilized syringe, which contains: Poly
Sponsors
Medisa Ara Gostar Iranian company
Eligibility
Sex/Gender
All
Age
25 Years to 60 Years
Inclusion criteria
Inclusion criteria: 25 - 60 Years women and men Signs of skin aging, such as reduced skin elasticity and the presence of lines and wrinkles on the face
Exclusion criteria
Exclusion criteria: Any cosmetic facial procedures during the last 6 months Autoimmune or immune deficiency diseases Patients with epilepsy and malignant tumors History of allergic diseases Presence of granulomas associated with sarcoidosis and Osler's nodes in endocarditis Taking medications such as NSAIDs, platelet aggregation inhibitors, anticoagulants, and immunosuppressants Active inflammation or infection Allergy to polydeoxyribonucleotides or lidocaine Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial skin elasticity. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: cutometery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: Based on patient's comments.;Signs of skin aging include lines and wrinkles. Timepoint: Before the intervention and 4 weeks after the last injection. Method of measurement: GAIS scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Nasimi
Tehran University of Medical Sciences
Outcome results
None listed